Inventor
FRIEDMAN LORI
US23 patents
⚠️ This page may combine multiple inventors who share the name “FRIEDMAN LORI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EXELIXIS INC
9 patentsUS7785805B2Aug 31, 2010
MAN2As as modifiers of the IGFR pathway and methods of use
EXELIXIS INC4 citations58
US7993829B2Aug 9, 2011
HPRP4s modifiers of the p53 pathway and methods of use
EXELIXIS INC2 citations56
US6924117B2Aug 2, 2005
Human RRP sequences and methods of use
EXELIXIS INC2 citations55
US6762291B1Jul 13, 2004
Insect p53 tumor suppressor genes and proteins
EXELIXIS INC2 citations54
US6972179B2Dec 6, 2005
RRP sequences and knockout mice and uses thereof
EXELIXIS INC0 citations50
US6927022B2Aug 9, 2005
HADHs as modifiers of the p21 pathway and methods of use
EXELIXIS INC0 citations49
US7943302B2May 17, 2011
C20ORF23 as modifier of the IGFR pathway and methods of use
EXELIXIS INC0 citations48
US7888047B2Feb 15, 2011
PDEs as modifiers of the IGFR pathways and methods of use
EXELIXIS INC1 citations48
US7049088B2May 23, 2006
PRMTs as modifiers of the p53 pathway and methods of use
EXELIXIS INC1 citations47
GENENTECH INC
4 patentsUS9107926B2Aug 18, 2015
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
GENENTECH INC28 citations93
US9855270B2Jan 2, 2018
Methods and compositions for modulating estrogen receptor mutants
GENENTECH INC4 citations71
US9335320B2May 10, 2016
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
GENENTECH INC1 citations51
US10004748B2Jun 26, 2018
Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib
GENENTECH INC0 citations43
UNIV CALIFORNIA
3 patentsUS5622829AApr 22, 1997
Genetic markers for breast, ovarian, and prostatic cancer
UNIV CALIFORNIA66 citations93
US5821328AOct 13, 1998
Genetic markers for breast, ovarian, and prostatic cancer
UNIV CALIFORNIA18 citations89
US6512091B1Jan 28, 2003
Genetic Markers for breast, ovarian, and prostatic cancer
UNIV CALIFORNIA4 citations60
BELVIN MARCIA
3 patentsUS8247397B2Aug 21, 2012
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
BELVIN MARCIA40 citations90
US8604014B2Dec 10, 2013
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use
BELVIN MARCIA26 citations89
US8771942B2Jul 8, 2014
SCDs as modifiers of the p53 pathway and methods of use
BELVIN MARCIA0 citations39